tyc7111cc太阳成

News-Excellence achieved through unity and diversity. Convergence and condensation result in crystallization.

tyc7111cc太阳成

Excellence achieved through unity and diversity. Convergence and condensation result in crystallization.

Homepage > News
18 2025-11

Avibactam sodium from Jingjing Pharmaceutical: An important β-lactamase inhibitor, effective against drug-resistant bacteria

Avibactam sodium is an important β-lactamase inhibitor. It has weak antibacterial activity on its own, but by inhibiting the β-lactamases produced by bacteria, it protects the antibiotics used in combination with it from being destroyed, thereby effectively combating drug-resistant bacteria. Project details: Chinese name: Avibactam Sodium; English name: Avibactam Sodium; CAS number: 1…
11 2025-11

Adhering to the philosophy of "Reliable medicines, made with care," we aim to create a high-quality product system.

Adhering to the philosophy of “trustworthy medicines, made with care,” we aim to create a high-quality product system. Centered around synthetic biotechnology, we have established four major professional technical platforms: biofermentation, bioenzyme catalysis, chemical synthesis, and crystallization control. Jingjing Pharmaceutical has developed a comprehensive set of production processes for specialty active pharmaceutical ingredients and amino acid products...
07 2025-11

Jingjing Pharmaceutical: An innovator driven by synthetic biology

Jingjing Pharmaceutical Co., Ltd. uses synthetic biology as its core technological engine, leveraging professional technical platforms such as biofermentation, bioenzyme catalysis, chemical synthesis, and crystal control. By integrating technological achievements and innovative elements from multiple disciplines, the company focuses on enhancing its ability to transform research results and its advantages in industrial incubation. The company has developed a range of products, including specialty active pharmaceutical ingredients, amines, and more...
10 2025-09

Fill in the blanks! The group standard for α-ketoglutaric acid, drafted under the leadership of the Crystalline Pharmaceuticals company, has been officially released and is now in effect.

Recently, an important piece of news came from the China International Economic and Technical Cooperation Promotion Association: Four group standards, which were drafted and participated in the compilation by Jingjing Pharmaceutical Co., Ltd., have been released. These standards are titled “Natural α-Ketoglutaric Acid,” “Technical Specifications for the Separation and Purification of α-Ketoglutaric Acid,” “Technical Procedures for the Synthesis of α-Ketoglutaric Acid by Microbial Fermentation,” and “α...”
22 2025-08

Public Notice on the 2025 Hebei Province Science and Technology Progress Award Project "Key Technologies and Industrialization of a Green Production Process for the Preparation of Calcium D-Pantothenate by Enzyme Method"

According to the requirements of the "Notice on the Nominations for the Hebei Provincial Science and Technology Awards for the Year 2025" issued by the Hebei Provincial Department of Science and Technology (Ji Ke Cheng Shi (2025) No. 11), our unit plans to submit a project for the Hebei Provincial Science and Technology Progress Award for the year 2025, which is "Key Technologies for a Green Production Process of D-Panthenic Acid Calcium by Enzymatic Method and Its Industrialization" (Nominating Unit:...).
06 2025-08

Jingjing Pharmaceutical: Synthetic biology drives innovation, and the liposome platform opens a new era in bioactive delivery.

At the forefront of the booming life sciences and healthcare industries, Jingjing Pharmaceutical uses cutting-edge synthetic biology technology as its core engine to continuously inject innovative vitality into the global market. We specialize in the research, development, and production of amino acids, vitamins, and their derivative products, which provide strong support and impetus for various fields such as pharmaceuticals, food, and agriculture.
19 2025-06

Several key raw materials, including AKG, have obtained food production licenses, laying a solid foundation for the health industry.

In the heat of midsummer, June, there are frequent pieces of good news! Following the successful certification of products such as γ-aminobutyric acid (GABA) and L-aspartic acid, Jingjing Pharmaceutical is once again experiencing a glorious moment. Its portfolio now includes AKG (α-ketoglutaric acid, 2-oxoglutaric acid), β-alanine, calcium aspartate, L-arginine, isomaltulose, ferrous fumarate, L-malic acid, and more...
04 2025-06

Jingjing Pharmaceutical produces 30,000 tons of aspartic acid annually, and the price has been reduced to the lowest possible level.

Strict control over raw materials to ensure purity; Biological enzyme catalysis for leading quality; Precise control for worry-free crystallization; Full traceability to address any issues; Multiple uses for the same material, ensuring stable quality; Same purity at a lower price, with the option for customization!
26 2025-05

Crystalline Pharmaceutical's Global Exhibition Highlights | Zhengzhou, Barcelona, Guangzhou: Three Events Linked Together to Embrace a Healthy Future!

Jingjing Pharmaceutical makes a grand appearance at three major industry events, bringing its core products and innovative technologies. We sincerely invite colleagues from all fields to join us for exchanges and jointly explore new development opportunities! FIE ASia Huatao·2025 Henan (Zhengzhou) International Food Additives and Ingredients Expo: Date: May 23-25 Location: Zhengzhou Zhongyuan International Expo Center Booth: A25,...
24 2025-05

The 2024 Annual General Meeting of Shareholders of Jingjing Pharmaceutical Co., Ltd. was successfully held.

On May 16th, the 2024 annual general meeting of shareholders of Jingjing Pharmaceutical was successfully held. The meeting was chaired by Chairman Li Binshui. During the meeting, Chairman Li Binshui provided a comprehensive overview of the company's operations for the year 2024 and the work plan for 2025. He also focused on the company's latest developments, new product research and development, future development strategies, technological innovations, and talent management...